3 ms·

>Vaccines are available for all Americans 16 and older. I'm not sure when this occurred nationwide, but California made vaccines avaiable to everyone 16 and old

>Vaccines are available for all Americans 16 and older. I'm not sure when this occurred nationwide, but California made vaccines avaiable to everyone 16 and older since April 15, and other states did so before then. Despite the vaccine not being available to many people in the UK (people aged 16-40) that a greater percentage of adults in the UK have received at least one dose. Some of that can be attributed to lower rates of vaccine hesitancy, but some of it is surely related to the NHS being better at outreach than the fragmented healthcare system in the US.

TMWNN 5y ago
>Despite the vaccine not being available to many people in the UK (people aged 16-40) that a greater percentage of adults in the UK have received at least one dose. Most countries have prioritizing giving one dose to as many as possible first and delaying the second dose, believing that doing so is preferable to prioritizing second doses when the goal is the most widespread (as opposed to optimal per person) immunity possible. The US hasn't had to do this because it bought enough vaccines last year for every American from each of the countries working on a vaccine, leading to the current luxury of being able to schedule second does at the recommended interval. The UK is in better shape than the EU or Canada but does not have as much as the US, leading to its strategy. >Some of that can be attributed to lower rates of vaccine hesitancy Vaccine hesitancy in the UK is unusually low, I agree, based on the YouGov data I've seen, but overall anti-vaccine sentiment is higher in Europe than in the US. https://www.forbes.com/sites/joshuacohen/2021/03/08/covid-19-vaccine-hesitancy-is-worse-in-eu-than-us/?sh=22d7ce58611f https://www.forbes.com/sites/joshuacohen/2021/03/08/covid-19... >but some of it is surely related to the NHS being better at outreach than the fragmented healthcare system in the US. There is no evidence of this. In the US, it is impossible to go anywhere without hearing or seeing vaccine offers. In addition to government- and hospital-run mass vaccination sites, every chain pharmacy offers vaccination at every location including Walgreens. Meanwhile, Walgreens' UK affiliate Boots only offers vaccination at 17 locations (https://www.boots.com/health-pharmacy/covid-19-information-products-and-testing/covid-vaccination https://www.boots.com/health-pharmacy/covid-19-information-p...). Superdrug offers it at a handful of locations as well. (https://www.superdrug.com/corona-update/faq https://www.superdrug.com/corona-update/faq)
- naturalauction 5y ago
  Perhaps you are right, I am just surprised with almost a month of unrestricted vaccine uptake opportunities in the US, the rate of vaccination (people who have taken at least one dose) is significantly lower than the UK, which as you note is experiencing significant supply difficulties. I also think that dealing with vaccine hesitancy effectively is the mark of a good healthcare system, but of course there can be many causes of vaccine hesitancy and there is no good way to measure outreach.
  - TMWNN 5y ago
    >I also think that dealing with vaccine hesitancy effectively is the mark of a good healthcare system, but of course there can be many causes of vaccine hesitancy and there is no good way to measure outreach. The French health care system consistently rates as among the best in the world. France has the highest vaccine hesitancy among developed countries (https://www.theatlantic.com/international/archive/2021/03/france-vaccine-hesitancy-astra-zeneca/618316/ https://www.theatlantic.com/international/archive/2021/03/fr...).

TMWNN 5y ago

>Despite the vaccine not being available to many people in the UK (people aged 16-40) that a greater percentage of adults in the UK have received at least one dose. Most countries have prioritizing giving one dose to as many as possible first and delaying the second dose, believing that doing so is preferable to prioritizing second doses when the goal is the most widespread (as opposed to optimal per person) immunity possible. The US hasn't had to do this because it bought enough vaccines last year for every American from each of the countries working on a vaccine, leading to the current luxury of being able to schedule second does at the recommended interval. The UK is in better shape than the EU or Canada but does not have as much as the US, leading to its strategy. >Some of that can be attributed to lower rates of vaccine hesitancy Vaccine hesitancy in the UK is unusually low, I agree, based on the YouGov data I've seen, but overall anti-vaccine sentiment is higher in Europe than in the US. https://www.forbes.com/sites/joshuacohen/2021/03/08/covid-19-vaccine-hesitancy-is-worse-in-eu-than-us/?sh=22d7ce58611f https://www.forbes.com/sites/joshuacohen/2021/03/08/covid-19... >but some of it is surely related to the NHS being better at outreach than the fragmented healthcare system in the US. There is no evidence of this. In the US, it is impossible to go anywhere without hearing or seeing vaccine offers. In addition to government- and hospital-run mass vaccination sites, every chain pharmacy offers vaccination at every location including Walgreens. Meanwhile, Walgreens' UK affiliate Boots only offers vaccination at 17 locations (https://www.boots.com/health-pharmacy/covid-19-information-products-and-testing/covid-vaccination https://www.boots.com/health-pharmacy/covid-19-information-p...). Superdrug offers it at a handful of locations as well. (https://www.superdrug.com/corona-update/faq https://www.superdrug.com/corona-update/faq)

naturalauction 5y ago
Perhaps you are right, I am just surprised with almost a month of unrestricted vaccine uptake opportunities in the US, the rate of vaccination (people who have taken at least one dose) is significantly lower than the UK, which as you note is experiencing significant supply difficulties. I also think that dealing with vaccine hesitancy effectively is the mark of a good healthcare system, but of course there can be many causes of vaccine hesitancy and there is no good way to measure outreach.
- TMWNN 5y ago
  >I also think that dealing with vaccine hesitancy effectively is the mark of a good healthcare system, but of course there can be many causes of vaccine hesitancy and there is no good way to measure outreach. The French health care system consistently rates as among the best in the world. France has the highest vaccine hesitancy among developed countries (https://www.theatlantic.com/international/archive/2021/03/france-vaccine-hesitancy-astra-zeneca/618316/ https://www.theatlantic.com/international/archive/2021/03/fr...).